Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel P Haas

Showing results (31-40 of 81) with videos related to

Pageof 9
Sort By:
Anticancer Research|January 30, 2003
Correlation of the genotypes for N-acetyltransferases 1 and 2 with double bladder and prostate cancers in a case-comparison studyChing Y Wang, Richard F Jones, Maria Debiec-Rychter, et al.
In Vivo (Athens, Greece)|June 10, 2003
Combination of radiation and vaccination with autologous tumor cells expressing IL-2, IFN-gamma and GM-CSF for treatment of murine renal carcinomaAtul Maini, Nobuyasu Nishisaka, Yoshihisa Kinoshita, et al.
In Vivo (Athens, Greece)|April 17, 2009
MnSOD genotype and prostate cancer risk as a function of NAT genotype and smoking statusTaro Iguchi, Shozo Sugita, Ching Y Wang, et al.
International Journal of Cancer|October 25, 2002
Inhibition of prostate-specific membrane antigen (PSMA)-positive tumor growth by vaccination with either full-length or the C-terminal end of PSMAKatsuyuki Kuratsukuri, Tomomichi Sone, Ching Y Wang, et al.
European Urology|July 18, 2002
Induction of antibodies against prostate-specific membrane antigen (PSMA) by vaccination with a PSMA DNA vectorKatsuyuki Kuratsukuri, Ching Y Wang, Tomomichi Sone, et al.
The Canadian Journal of Urology|February 29, 2008
The worldwide epidemiology of prostate cancer: perspectives from autopsy studiesGabriel P Haas, Nicolas Delongchamps, Otis W Brawley, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|June 8, 2001
Antitumor Effect on Murine Renal Cell Carcinoma by Autologous Tumor Vaccines Genetically Modified with Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-6 CellsYoshihisa Kinoshita, Takuro Kono, Ryoji Yasumoto, et al.
Neurourology and Urodynamics|September 25, 2012
Finding unrecognized information in overactive bladder clinical trial data: a new approach to understanding placebo and treatment effectsNorman R Zinner, Larry P Ammann, Gabriel P Haas, et al.
Future Oncology (London, England)|October 15, 2024
Enzalutamide in metastatic hormone-sensitive prostate cancer: A plain language summary of the ARCHES and ENZAMET follow-up studiesAndrew J Armstrong, Arun A Azad, Ciara Conduit, et al.
World Journal of Surgery|March 24, 2006
Expression of prostate-specific membrane antigen in normal and malignant human tissuesYoshihisa Kinoshita, Katsuyuki Kuratsukuri, Steve Landas, et al.
Pageof 9

Showing results (31-40 of 81) with videos related to

Sort By:
Pageof 9
Anticancer Research|January 30, 2003
Correlation of the genotypes for N-acetyltransferases 1 and 2 with double bladder and prostate cancers in a case-comparison studyChing Y Wang, Richard F Jones, Maria Debiec-Rychter, et al.
In Vivo (Athens, Greece)|June 10, 2003
Combination of radiation and vaccination with autologous tumor cells expressing IL-2, IFN-gamma and GM-CSF for treatment of murine renal carcinomaAtul Maini, Nobuyasu Nishisaka, Yoshihisa Kinoshita, et al.
In Vivo (Athens, Greece)|April 17, 2009
MnSOD genotype and prostate cancer risk as a function of NAT genotype and smoking statusTaro Iguchi, Shozo Sugita, Ching Y Wang, et al.
International Journal of Cancer|October 25, 2002
Inhibition of prostate-specific membrane antigen (PSMA)-positive tumor growth by vaccination with either full-length or the C-terminal end of PSMAKatsuyuki Kuratsukuri, Tomomichi Sone, Ching Y Wang, et al.
European Urology|July 18, 2002
Induction of antibodies against prostate-specific membrane antigen (PSMA) by vaccination with a PSMA DNA vectorKatsuyuki Kuratsukuri, Ching Y Wang, Tomomichi Sone, et al.
The Canadian Journal of Urology|February 29, 2008
The worldwide epidemiology of prostate cancer: perspectives from autopsy studiesGabriel P Haas, Nicolas Delongchamps, Otis W Brawley, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|June 8, 2001
Antitumor Effect on Murine Renal Cell Carcinoma by Autologous Tumor Vaccines Genetically Modified with Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-6 CellsYoshihisa Kinoshita, Takuro Kono, Ryoji Yasumoto, et al.
Neurourology and Urodynamics|September 25, 2012
Finding unrecognized information in overactive bladder clinical trial data: a new approach to understanding placebo and treatment effectsNorman R Zinner, Larry P Ammann, Gabriel P Haas, et al.
Future Oncology (London, England)|October 15, 2024
Enzalutamide in metastatic hormone-sensitive prostate cancer: A plain language summary of the ARCHES and ENZAMET follow-up studiesAndrew J Armstrong, Arun A Azad, Ciara Conduit, et al.
World Journal of Surgery|March 24, 2006
Expression of prostate-specific membrane antigen in normal and malignant human tissuesYoshihisa Kinoshita, Katsuyuki Kuratsukuri, Steve Landas, et al.
Pageof 9